This suggests that the overall oncogenic output of Cdk5 may depend on the availability of its substrates; in many tumors, its pro-tumorigenic role may become dominant precisely because tumor-suppressive substrates like DLC1 are downregulated [120]. Here, CDK5 is linked to neoplasm.